SCHEMBL6296941

SCHEMBL6296941

CC(=O)Oc1ccc(-c2ccc(C(=O)CC(CCN3C(=O)c4ccccc4C3=O)(C(=O)OC(C)(C)C)C(=O)OC(C)(C)C)cc2)cc1

nearest known ligand 0.42

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
NPC1 O15118 2/20 0.42
MMP2 P08253 3/20 0.41
MMP9 P14780 3/20 0.41
ALDH1A1 P00352 4/20 0.39
HPGD P15428 2/20 0.39
KDM4E B2RXH2 1/20 0.39
RECQL P46063 1/20 0.39
KMT2A Q03164 6/20 0.39
HSD17B10 Q99714 3/20 0.39
POLB P06746 2/20 0.39
MEN1 O00255 2/20 0.39
GAA P10253 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
RAB9A P51151 1/20 0.39
TDP1 Q9NUW8 1/20 0.37
MAPT P10636 1/20 0.36
MMP3 P08254 1/20 0.36
MMP13 P45452 1/20 0.36
ELANE P08246 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7574583 0.89 MEN1 (0.46) NPC1MMP2MMP9ALDH1A1HPGD
SCHEMBL6293053 0.88 MMP2 (0.43) NPC1MMP2MMP9ALDH1A1GAA
SCHEMBL7860396 0.77 NPC1 (0.60) NPC1MMP2MMP9ALDH1A1KMT2A
SCHEMBL6292109 0.72 MMP2 (0.51) NPC1MMP2MMP9ALDH1A1HPGD
SCHEMBL9226627 0.72 MEN1 (0.46) KDM4EKMT2AHSD17B10POLBMEN1
SCHEMBL7580305 0.69 HTT (0.45) NPC1ALDH1A1HPGDKDM4EKMT2A
SCHEMBL7862778 0.68 GSK3B (0.59) NPC1MMP2MMP9ALDH1A1KMT2A
SCHEMBL7861865 0.67 THRA (0.41) HPGDHSD17B10POLBGAASMN1; SMN2
SCHEMBL7861710 0.67 GSK3B (0.49) NPC1MMP2MMP9ALDH1A1KMT2A
SCHEMBL17150420 0.67 KMT2A (0.48) NPC1ALDH1A1HPGDKDM4EKMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6900194-B1 Use of substituted 4-biarylbutyric and 5-biarylpentanoic acid derivatives as matrix metalloprotease inhibitors for the treatment of respiratory diseases BAYER AKTIENGESELLSCHAFT (DE) 2005-05-31 US disclosed